FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us

Resources

  • Videos
  • Research Reports
  • FAQ

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
Monterey Bio Acquisition Corporation Stock AnalysisComprehensive stock analysis for Monterey Bio Acquisition Corporation (MTRYU) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisMTRYU
MTRYU
Monterey Bio Acquisition Corporation
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
MTRYU
Home🔹Stocks🔹Monterey Bio Acquisition Corporation

Monterey Bio Acquisition Corporation

MTRYU•NASDAQ

Monterey Bio Acquisition Corporation

MTRYU•NASDAQ
Market cap
$45.32M
Sentiment

Your view on MTRYU

Mkt Cap
$45.32M
Sentiment
Your view
MTRYU
Monterey Bio Acquisition Corporation
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
MTRYU
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Monterey Bio Acquisition Corporation

Industry
Shell Companies
Sector
Financial Services
CEO
Murat Omur
Headquarters
17 State Street, New York City, NY, US
Industry
Shell Companies
Sector
Financial Services
CEO
Murat Omur
Headquarters
17 State Street, New York City, NY, US
Description

Monterey Bio Acquisition Corporation, founded in New York, New York, in 2020, does not currently have significant business operations. Its sole purpose is to identify and complete a business combination, such as a merger, acquisition, or stock exchange, with one or more companies in the biotechnology sector. The firm officially changed its name to Monterey Bio Acquisition Corporation in April 2021, having previously been known as Chardan FinTech Acquisition Corp.

FRC Research

Media

Infographics, videos, and posts covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks the stock is worth vs. the current price.

FRC's fair value estimate for Monterey Bio Acquisition Corporation, and the rating behind it. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Valuation, profitability, liquidity and leverage ratios for Monterey Bio Acquisition Corporation. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Dividend history, yield and payout sustainability for Monterey Bio Acquisition Corporation. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Reported vs. expected earnings history for Monterey Bio Acquisition Corporation. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Income statement, balance sheet and cash flow history for Monterey Bio Acquisition Corporation. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Monterey Bio Acquisition Corporation valued side by side against its closest peers. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.

Ownership & News

Institutional Ownership

Which funds and firms own the stock.

Which institutions hold Monterey Bio Acquisition Corporation, and how their positions are changing. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.

Insider Trading

Recent buying and selling by company executives.

Buying and selling by Monterey Bio Acquisition Corporation executives and directors. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

U.S. Senate disclosures naming Monterey Bio Acquisition Corporation. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.

House Trading

U.S. Representative disclosures filed under the STOCK Act.

U.S. House of Representatives disclosures naming Monterey Bio Acquisition Corporation. Representatives' reported transactions in this security, shown next to the company's fundamentals.

News

Latest headlines and market coverage.

Latest headlines and company announcements for Monterey Bio Acquisition Corporation. Press releases and market coverage, newest first.

News

Latest Market News